The partners will screen for molecules that could revive metabolic activity in heart tissue damaged by cardiovascular disease or failure.
The firm will offer the New Objective Digital PicoView 450 Source nanospray technology for use with its mass spectrometry systems.
Investigators from SomaLogic and elsewhere found proteins whose expression levels vary in Duchenne muscular dystrophy, often in conjunction with patients' age.
The investigators used the technique to identify two novel secretome targets and then confirmed them to be elevated in the blood of women with cancer.
The study, funded last month by the NIH, will use SRM-MS to identify proteins from a subset of promising pathways that are associated with DKD patients' progression to end-stage disease.
In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.
The new Riken president outlines some of his plans for the institute.
The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.
An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.